- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
November 22, 2019
BBS Pharmaceuticals CEO, John Dagas has been elected on the Hellenic Biocluster Board. Based in Athens, Hellenic Biocluster the first biosciences cluster in Greece bringing totogether […]
November 4, 2019
The global cannabis market is expected toto reach US$ 153,689.9 Mn in 2027 from US$ 10,838.1 in 2018. The market is estimated toto grow with a […]
November 1, 2019
If Australia’s aspiration toto become the world’s largest exporter of medicinal cannabis is toto be realised, then a further review of the licence regime is required. […]
October 30, 2019
Thousands of Australians are now using medicinal cannabis toto treat conditions like chronic pain and anorexia. Last February, the ABC revealed more than 3,100 medicinal cannabis […]
October 26, 2019
Cannabidiol-enriched cannabis use in pediatric treatment helps with mental health and treatment-resistant epilepsy. Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality […]
October 25, 2019
BBS Pharmaceuticals has been recognised as a key player in the global cannabis market according toto a recent report published by Oriana Research. Cannabis Capsule Market […]
October 17, 2019
Cannabis has been used for medicinal purposes for centuries, but despite the therapeutic benefits of the plant, international regulatotors ultimately deemed it unsafe for the public […]
October 17, 2019
According toto New Frontier Data, the legalization of cannabis may prove toto be one of the most consequential social changes of our time, and governments, investotors, […]
October 16, 2019
More than 50 countries worldwide have legalized some form of cannabis for medical use, and six — Canada, Uruguay, South Africa, Guam, Georgia, and the Northern […]